Coegin PharmaNGM:COEGIN +3.72%29 FCF Margin % is -1,926.37% as of Mar. 2026. GuruFocus rates NGM:COEGIN with a GF Score™ of 29/100. The stock has 2 warning signs investors should review. Among 958 Biotechnology companies, Coegin Pharma ranks worse than 90.29% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Coegin Pharma's Free Cash Flow for the
three
months ended in Mar. 2026 was kr-5.63 Mil. Coegin Pharma's Revenue for the
three
months ended in Mar. 2026 was kr0.29 Mil. Therefore, Coegin Pharma's FCF Margin % for the quarter that ended in Mar. 2026 was -1,926.37%.
The historical rank and industry rank for Coegin Pharma's FCF Margin % or its related term are showing as below:
NGM:COEGIN'
s FCF Margin % Range Over the Past 10 Years
Min: -21714.29 Med: -2378.7 Max: -31.91
Current: -4870.35
During the past 9 years, the highest FCF Margin % of Coegin Pharma was -31.91%. The lowest was -21714.29%. And the median was -2378.70%.
NGM:COEGIN's FCF Margin % is ranked worse than 90.29% of 958
companies
in the Biotechnology industry
Industry Median: -85.21
vs NGM:COEGIN: -4870.35
Coegin Pharma FCF Margin % Related Terms
Coegin Pharma FCF Margin % Historical Data
* Premium members only.
The historical data trend for Coegin Pharma's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGM:COEGIN vs VRTX, REGN, ALNY: FCF Margin % Comparison
For the Biotechnology subindustry, Coegin Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coegin Pharma FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Coegin Pharma's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Coegin Pharma's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coegin Pharma (NGM:COEGIN) has a FCF Margin % of -1,926.37% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Coegin Pharma and its competitors. According to the industry distribution chart, Coegin Pharma ranks #865 out of 958 companies in the Biotechnology industry, placing it in the top 90.3%.
Is Coegin Pharma's FCF Margin % too high?
Coegin Pharma's current FCF Margin % is -1,926.37%. Based on the distribution chart, Coegin Pharma ranks #865 out of 958 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Coegin Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Coegin Pharma's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Coegin Pharma ranks #865 out of 958 companies for FCF Margin %. This places Coegin Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Coegin Pharma and its competitors. Coegin Pharma's current FCF Margin % is -1,926.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coegin Pharma stock overvalued right now?
Coegin Pharma (NGM:COEGIN) has a current FCF Margin % of -1,926.37%. The current FCF Margin % is -1,926.37%. Coegin Pharma's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Coegin Pharma (NGM:COEGIN), the current FCF Margin % is -1,926.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Coegin Pharma AB is a Swedish biotechnology company with projects in hair growth, skin pigmentation, heart attacks, and leukemia. Its project portfolio builds on three distinct, patented technology platforms: the FOL peptide technology, the pigmentation peptide technology, and the cPLA2 alpha technology. The company's project portfolio consists of both cosmetic dermatology and drug development projects. Currently, it is focused on the cosmetic dermatology projects, which include the NPP-4 project for skin pigmentation and the Follicopeptide project for hair growth. In addition, the company's project portfolio also includes three drug development projects: FOL026, for the treatment of myocardial infarction (heart attack); AVX420 for the treatment of leukemia; and AVX001.
29GF Score
Get the complete analysis for NGM:COEGIN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:COEGIN has been successfully added to your 
